生物標記市場：按產品類型（功效、藥效學、預測）、按產品和服務（消耗品、服務、軟體）、按疾病、按用途- 2023-2030 年全球預測

全球生物標記市場預計到 2023 年將大幅成長，達到 606.7 億美元，複合年成長率為 14.10%，預計到 2030 年將達到驚人的 1536.7 億美元。

FPNV定位矩陣

FPNV定位矩陣對於評估全球生物標記市場至關重要。透過檢查業務策略和產品滿意度的關鍵指標，我們對供應商進行全面評估，使您能夠根據您的特定需求做出明智的資訊。這種進階分析將供應商分為四個像限，並取得了不同程度的成功：前沿 (F)、探路者 (P)、利基 (N) 和重要 (V)。

市佔率分析

市場佔有率分析可以深入了解供應商在特定市場領域的當前地位。比較供應商對總收入、基本客群和其他關鍵指標的貢獻，可以幫助公司更好地了解他們在爭奪市場佔有率時的表現以及面臨的情況。該分析還揭示了特定行業的競爭程度、累積和合併的優勢以及研究基準年的合併特徵。

本報告提供了以下幾點見解：

1. 市場滲透率：提供有關主要企業所服務的市場的全面資訊。

2. 市場開發：提供有關利潤豐厚的新興市場的詳細資訊，並分析其在成熟市場的滲透率。

3. 市場多元化：提供有關新產品發布、未開發領域、最新發展和投資的詳細資訊。

4.市場趨勢：全面了解COVID-19、俄羅斯-烏克蘭衝突和高通膨的累積影響。

5.競爭評估與資訊：對主要企業的市場佔有率、策略、產品、認證、法規狀況、專利狀況、製造能力等進行綜合評估。

6. 產品開發與創新：提供對未來技術、研發活動和突破性產品開發的見解。

本報告回答了以下問題：

1.全球生物標記市場規模及預測是多少？

2.在預測期內，COVID-19 對全球生物標記市場的阻礙因素和影響為何？

3. 在預測期內，全球生物標記物市場需要投資哪些產品/細分市場/應用/領域？

4.你們在全球生物標記市場的競爭策略是什麼？

5. 全球生物標記市場的技術趨勢和法律規範是什麼？

6. 全球生物標記市場主要廠商的市佔率是多少？

7. 哪些型態和策略措施被認為適合進入全球生物標記市場？

目錄

第1章 前言

第2章 調查方法

第3章 執行摘要

第4章 市場概況

第5章 市場洞察

• 市場動態
  • 促進因素
    • 更多使用生物標記測試來監測慢性病的治療
    • 個人化醫療生物標記診斷應用的增加
    • 活性化生技和製藥領域的研發活動
  • 抑制因素
    • 生產成本高，生物標誌開發過程耗時。
  • 機會
    • 預測方法開發的最新進展

癌症治療的生物標記

• 結合先進技術開發高精度生物標記
• 任務
  • 與生物標記樣本採集和儲存相關的問題

程式

• 市場趨勢
• COVID-19 的累積影響
• 俄羅斯-烏克蘭衝突的累積影響
• 高通膨的累積效應
• 波特五力分析
• 價值鍊和關鍵路徑分析
• 法律規範
• 客戶客製化

第6章 生物標記市場：依類型

• 功效
• 藥效學
• 預測性的
• 預後
• 安全
• 代理人
• 檢驗

第7章 按產品和服務分類的生物標記市場

• 消耗品
• 服務
• 軟體

第8章 生物標記市場：依疾病分類

• 癌症
• 心血管疾病
• 免疫疾病
• 感染疾病
• 神經系統疾病

第9章 生物標記市場：依用途

• 診斷
• 疾病風險評估
• 藥物研發發現與開發
• 個人化醫療

第10章 美洲生物標記市場

• 阿根廷
• 巴西
• 加拿大
• 墨西哥
• 美國

第11章亞太生物標記市場

• 澳洲
• 中國
• 印度
• 印尼
• 日本
• 馬來西亞
• 菲律賓
• 新加坡
• 韓國
• 台灣
• 泰國
• 越南

第12章歐洲/中東/非洲生物標記市場

• 丹麥
• 埃及
• 芬蘭
• 法國
• 德國
• 以色列
• 義大利
• 荷蘭
• 奈及利亞
• 挪威
• 波蘭
• 卡達
• 俄羅斯
• 沙烏地阿拉伯
• 南非
• 西班牙
• 瑞典
• 瑞士
• 土耳其
• 阿拉伯聯合大公國
• 英國

第13章競爭形勢

• FPNV定位矩陣
• 市佔率分析：主要企業
• 競爭情境分析：主要企業
  • 併購
  • 合約、合作和夥伴關係
  • 新產品發布和功能增強
  • 投資、資金籌措
  • 獎項/獎勵/擴展

第14章上市公司名單

第15章附錄

• 討論指南
• 關於許可證和定價

The Global Biomarkers Market is forecasted to grow significantly, with a projected USD 60.67 billion in 2023 at a CAGR of 14.10% and expected to reach a staggering USD 153.67 billion by 2030.

The Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and High Inflation is expected to have significant long-term effects on the Global Biomarkers Market. The ongoing research considers the changes in consumer behavior, supply chain disruptions, and government interventions caused by the pandemic. Similarly, the report considers the ongoing political and economic uncertainty in Eastern Europe caused by the Russia-Ukraine Conflict and its potential implications for demand-supply balances, pressure on pricing variants, and import/export and trading. Additionally, the report addresses the impact of High Inflation on the global economy and details fiscal policies measuring and reducing its effects on demand, supply, cash flow, and currency exchange.

Market Segmentation & Coverage:

This research report categorizes the Global Biomarkers Market in order to forecast the revenues and analyze trends in each of following sub-markets:

Based on Type, market is studied across Efficacy, Pharmacodynamics, Predictive, Prognostic, Safety, Surrogate, and Validation. The Efficacy commanded largest market share of 23.65% in 2022, followed by Validation.

Based on Product & Service, market is studied across Consumables, Services, and Software. The Consumables commanded largest market share of 50.87% in 2022, followed by Services.

Based on Disease, market is studied across Cancer, Cardiovascular Diseases, Immunological Diseases, Infectious Diseases, and Neurological Diseases. The Cancer commanded largest market share of 51.17% in 2022, followed by Neurological Diseases.

Based on Application, market is studied across Diagnostic, Disease Risk Assessment, Drug Discovery & Development, and Personalized Medicine. The Diagnostic commanded largest market share of 39.73% in 2022, followed by Drug Discovery & Development.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom. The Americas commanded largest market share of 39.50% in 2022, followed by Europe, Middle East & Africa.

Market Statistics:

The report provides market sizing and forecasts across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF; multiple currency support helps organization leaders to make well-informed decisions. In this report, 2018 to 2021 are considered as historical years, 2022 is base year, 2023 is estimated year, and years from 2024 to 2030 are considered as forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix is essential for assessing the Global Biomarkers Market. It provides a comprehensive evaluation of vendors by examining key metrics within Business Strategy and Product Satisfaction, allowing users to make informed decisions based on their specific needs. This advanced analysis then organizes these vendors into four distinct quadrants, which represent varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital(V).

Market Share Analysis:

The Market Share Analysis offers an insightful look at the current state of vendors in a particular market space. By comparing vendor contributions to overall revenue, customer base, and other key metrics, we can give companies a greater understanding of their performance and what they are up against when competing for market share. The analysis also sheds light on just how competitive any given sector is about accumulation, fragmentation dominance, and amalgamation traits over the base year period studied.

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on the market offered by the key players

2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes penetration across mature segments of the markets

3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments

4. Market Trends: Provides comprehensive understanding of the Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and the High Inflation

5. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players

6. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

1. What is the market size and forecast of the Global Biomarkers Market?

2. What are the inhibiting factors and impact of COVID-19 shaping the Global Biomarkers Market during the forecast period?

3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Biomarkers Market?

4. What is the competitive strategic window for opportunities in the Global Biomarkers Market?

5. What are the technology trends and regulatory frameworks in the Global Biomarkers Market?

6. What is the market share of the leading vendors in the Global Biomarkers Market?

7. What modes and strategic moves are considered suitable for entering the Global Biomarkers Market?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Limitations
• 1.7. Assumptions
• 1.8. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

• 4.1. Introduction
• 4.2. Biomarkers Market, by Type, 2022 vs 2030
• 4.3. Biomarkers Market, by Product & Service, 2022 vs 2030
• 4.4. Biomarkers Market, by Disease, 2022 vs 2030
• 4.5. Biomarkers Market, by Application, 2022 vs 2030
• 4.6. Biomarkers Market, by Region, 2022 vs 2030

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Increasing usage of biomarkers testing owing to monitor the treatment of chronic disease
    • 5.1.1.2. Increasing biomarkers diagnostic application for personalized medicine
    • 5.1.1.3. Rising research and development activities in biotechnology and pharmaceutical sector
  • 5.1.2. Restraints
    • 5.1.2.1. High cost associated with production and lengthy time process for biomarkers development
  • 5.1.3. Opportunities
    • 5.1.3.1. Recent advancements in the development of prognostic and diagnostic

biomarkers for cancer treatments

• 5.1.3.2. Integration of advanced technologies to develop biomarkers that provide high accuracy
• 5.1.4. Challenges
  • 5.1.4.1. Issues associated with collection and storage of samples in biomarkers

procedures

• 5.2. Market Trends
• 5.3. Cumulative Impact of COVID-19
• 5.4. Cumulative Impact of Russia-Ukraine Conflict
• 5.5. Cumulative Impact of High Inflation
• 5.6. Porter's Five Forces Analysis
  • 5.6.1. Threat of New Entrants
  • 5.6.2. Threat of Substitutes
  • 5.6.3. Bargaining Power of Customers
  • 5.6.4. Bargaining Power of Suppliers
  • 5.6.5. Industry Rivalry
• 5.7. Value Chain & Critical Path Analysis
• 5.8. Regulatory Framework
• 5.9. Client Customization

6. Biomarkers Market, by Type

• 6.1. Introduction
• 6.2. Efficacy
• 6.3. Pharmacodynamics
• 6.4. Predictive
• 6.5. Prognostic
• 6.6. Safety
• 6.7. Surrogate
• 6.8. Validation

7. Biomarkers Market, by Product & Service

• 7.1. Introduction
• 7.2. Consumables
• 7.3. Services
• 7.4. Software

8. Biomarkers Market, by Disease

• 8.1. Introduction
• 8.2. Cancer
• 8.3. Cardiovascular Diseases
• 8.4. Immunological Diseases
• 8.5. Infectious Diseases
• 8.6. Neurological Diseases

9. Biomarkers Market, by Application

• 9.1. Introduction
• 9.2. Diagnostic
• 9.3. Disease Risk Assessment
• 9.4. Drug Discovery & Development
• 9.5. Personalized Medicine

10. Americas Biomarkers Market

• 10.1. Introduction
• 10.2. Argentina
• 10.3. Brazil
• 10.4. Canada
• 10.5. Mexico
• 10.6. United States

11. Asia-Pacific Biomarkers Market

• 11.1. Introduction
• 11.2. Australia
• 11.3. China
• 11.4. India
• 11.5. Indonesia
• 11.6. Japan
• 11.7. Malaysia
• 11.8. Philippines
• 11.9. Singapore
• 11.10. South Korea
• 11.11. Taiwan
• 11.12. Thailand
• 11.13. Vietnam

12. Europe, Middle East & Africa Biomarkers Market

• 12.1. Introduction
• 12.2. Denmark
• 12.3. Egypt
• 12.4. Finland
• 12.5. France
• 12.6. Germany
• 12.7. Israel
• 12.8. Italy
• 12.9. Netherlands
• 12.10. Nigeria
• 12.11. Norway
• 12.12. Poland
• 12.13. Qatar
• 12.14. Russia
• 12.15. Saudi Arabia
• 12.16. South Africa
• 12.17. Spain
• 12.18. Sweden
• 12.19. Switzerland
• 12.20. Turkey
• 12.21. United Arab Emirates
• 12.22. United Kingdom

13. Competitive Landscape

• 13.1. FPNV Positioning Matrix
• 13.2. Market Share Analysis, By Key Player
• 13.3. Competitive Scenario Analysis, By Key Player
  • 13.3.1. Merger & Acquisition
    • 13.3.1.1. Theralink Acquires Immunotherapy Biomarker Patent From Vanderbilt University
    • 13.3.1.2. Mainz Biomed Acquires Entire Intellectual Property Portfolio For Its Colorectal Cancer Diagnostic Test Program
  • 13.3.2. Agreement, Collaboration, & Partnership
    • 13.3.2.1. ObvioHealth Signs R&D Partnership with A*STAR to Identify and Develop Novel Digital Biomarkers
    • 13.3.2.2. PrecisionLife Completes Agreement with King's College London to Enable New Precision Neuroscience Treatments in MND/ALS
    • 13.3.2.3. AriBio Co., Ltd. and Fujirebio Diagnostics, Inc. Announce Strategic Partnership to Advance Biomarker Development for Alzheimer's Disease and Neurodegeneration
    • 13.3.2.4. Vocal Biomarker Agreement Set To Benefit Patients With COPD in India
  • 13.3.3. New Product Launch & Enhancement
    • 13.3.3.1. Akoya Biosciences Launches PhenoCode Signature Panels to Accelerate Development of Predictive Biomarkers for Cancer Immunotherapy
  • 13.3.4. Investment & Funding
    • 13.3.4.1. Genialis Raises USD 13 Million to Build Clinical Biomarkers that Predict Patient Response
  • 13.3.5. Award, Recognition, & Expansion
    • 13.3.5.1. Abbott Receives FDA Clearance For First Commercially Available Lab-Based Blood Test To Help Evaluate Concussion

14. List of Company Mentioned

15. Appendix

• 15.1. Discussion Guide
• 15.2. License & Pricing

LIST OF FIGURES

• FIGURE 1. BIOMARKERS MARKET RESEARCH PROCESS
• FIGURE 2. BIOMARKERS MARKET SIZE, 2022 VS 2030
• FIGURE 3. BIOMARKERS MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. BIOMARKERS MARKET SIZE, BY TYPE, 2022 VS 2030 (%)
• FIGURE 5. BIOMARKERS MARKET SIZE, BY PRODUCT & SERVICE, 2022 VS 2030 (%)
• FIGURE 6. BIOMARKERS MARKET SIZE, BY DISEASE, 2022 VS 2030 (%)
• FIGURE 7. BIOMARKERS MARKET SIZE, BY APPLICATION, 2022 VS 2030 (%)
• FIGURE 8. BIOMARKERS MARKET SIZE, BY REGION, 2022 VS 2030 (%)
• FIGURE 9. BIOMARKERS MARKET DYNAMICS
• FIGURE 10. BIOMARKERS MARKET SIZE, BY TYPE, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 11. BIOMARKERS MARKET SIZE, BY PRODUCT & SERVICE, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 12. BIOMARKERS MARKET SIZE, BY DISEASE, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 13. BIOMARKERS MARKET SIZE, BY APPLICATION, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 14. AMERICAS BIOMARKERS MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 15. UNITED STATES BIOMARKERS MARKET SIZE, BY STATE, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 16. ASIA-PACIFIC BIOMARKERS MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 17. EUROPE, MIDDLE EAST & AFRICA BIOMARKERS MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 18. BIOMARKERS MARKET, FPNV POSITIONING MATRIX, 2022
• FIGURE 19. BIOMARKERS MARKET SHARE, BY KEY PLAYER, 2022

LIST OF TABLES

• TABLE 1. BIOMARKERS MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2022
• TABLE 3. BIOMARKERS MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. BIOMARKERS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 5. BIOMARKERS MARKET SIZE, BY EFFICACY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 6. BIOMARKERS MARKET SIZE, BY PHARMACODYNAMICS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 7. BIOMARKERS MARKET SIZE, BY PREDICTIVE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 8. BIOMARKERS MARKET SIZE, BY PROGNOSTIC, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. BIOMARKERS MARKET SIZE, BY SAFETY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. BIOMARKERS MARKET SIZE, BY SURROGATE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 11. BIOMARKERS MARKET SIZE, BY VALIDATION, BY REGION, 2018-2030 (USD MILLION)
• TABLE 12. BIOMARKERS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 13. BIOMARKERS MARKET SIZE, BY CONSUMABLES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. BIOMARKERS MARKET SIZE, BY SERVICES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 15. BIOMARKERS MARKET SIZE, BY SOFTWARE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 16. BIOMARKERS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
• TABLE 17. BIOMARKERS MARKET SIZE, BY CANCER, BY REGION, 2018-2030 (USD MILLION)
• TABLE 18. BIOMARKERS MARKET SIZE, BY CARDIOVASCULAR DISEASES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 19. BIOMARKERS MARKET SIZE, BY IMMUNOLOGICAL DISEASES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 20. BIOMARKERS MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 21. BIOMARKERS MARKET SIZE, BY NEUROLOGICAL DISEASES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 22. BIOMARKERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 23. BIOMARKERS MARKET SIZE, BY DIAGNOSTIC, BY REGION, 2018-2030 (USD MILLION)
• TABLE 24. BIOMARKERS MARKET SIZE, BY DISEASE RISK ASSESSMENT, BY REGION, 2018-2030 (USD MILLION)
• TABLE 25. BIOMARKERS MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, BY REGION, 2018-2030 (USD MILLION)
• TABLE 26. BIOMARKERS MARKET SIZE, BY PERSONALIZED MEDICINE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 27. AMERICAS BIOMARKERS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 28. AMERICAS BIOMARKERS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 29. AMERICAS BIOMARKERS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 30. AMERICAS BIOMARKERS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
• TABLE 31. AMERICAS BIOMARKERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 32. ARGENTINA BIOMARKERS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 33. ARGENTINA BIOMARKERS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 34. ARGENTINA BIOMARKERS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
• TABLE 35. ARGENTINA BIOMARKERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 36. BRAZIL BIOMARKERS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 37. BRAZIL BIOMARKERS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 38. BRAZIL BIOMARKERS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
• TABLE 39. BRAZIL BIOMARKERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 40. CANADA BIOMARKERS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 41. CANADA BIOMARKERS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 42. CANADA BIOMARKERS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
• TABLE 43. CANADA BIOMARKERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 44. MEXICO BIOMARKERS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 45. MEXICO BIOMARKERS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 46. MEXICO BIOMARKERS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
• TABLE 47. MEXICO BIOMARKERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 48. UNITED STATES BIOMARKERS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 49. UNITED STATES BIOMARKERS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 50. UNITED STATES BIOMARKERS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 51. UNITED STATES BIOMARKERS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
• TABLE 52. UNITED STATES BIOMARKERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 53. ASIA-PACIFIC BIOMARKERS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 54. ASIA-PACIFIC BIOMARKERS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 55. ASIA-PACIFIC BIOMARKERS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 56. ASIA-PACIFIC BIOMARKERS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
• TABLE 57. ASIA-PACIFIC BIOMARKERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 58. AUSTRALIA BIOMARKERS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 59. AUSTRALIA BIOMARKERS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 60. AUSTRALIA BIOMARKERS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
• TABLE 61. AUSTRALIA BIOMARKERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 62. CHINA BIOMARKERS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 63. CHINA BIOMARKERS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 64. CHINA BIOMARKERS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
• TABLE 65. CHINA BIOMARKERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 66. INDIA BIOMARKERS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 67. INDIA BIOMARKERS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 68. INDIA BIOMARKERS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
• TABLE 69. INDIA BIOMARKERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 70. INDONESIA BIOMARKERS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 71. INDONESIA BIOMARKERS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 72. INDONESIA BIOMARKERS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
• TABLE 73. INDONESIA BIOMARKERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 74. JAPAN BIOMARKERS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 75. JAPAN BIOMARKERS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 76. JAPAN BIOMARKERS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
• TABLE 77. JAPAN BIOMARKERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 78. MALAYSIA BIOMARKERS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 79. MALAYSIA BIOMARKERS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 80. MALAYSIA BIOMARKERS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
• TABLE 81. MALAYSIA BIOMARKERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 82. PHILIPPINES BIOMARKERS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 83. PHILIPPINES BIOMARKERS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 84. PHILIPPINES BIOMARKERS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
• TABLE 85. PHILIPPINES BIOMARKERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 86. SINGAPORE BIOMARKERS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 87. SINGAPORE BIOMARKERS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 88. SINGAPORE BIOMARKERS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
• TABLE 89. SINGAPORE BIOMARKERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 90. SOUTH KOREA BIOMARKERS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 91. SOUTH KOREA BIOMARKERS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 92. SOUTH KOREA BIOMARKERS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
• TABLE 93. SOUTH KOREA BIOMARKERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 94. TAIWAN BIOMARKERS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 95. TAIWAN BIOMARKERS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 96. TAIWAN BIOMARKERS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
• TABLE 97. TAIWAN BIOMARKERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 98. THAILAND BIOMARKERS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 99. THAILAND BIOMARKERS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 100. THAILAND BIOMARKERS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
• TABLE 101. THAILAND BIOMARKERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 102. VIETNAM BIOMARKERS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 103. VIETNAM BIOMARKERS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 104. VIETNAM BIOMARKERS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
• TABLE 105. VIETNAM BIOMARKERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 106. EUROPE, MIDDLE EAST & AFRICA BIOMARKERS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 107. EUROPE, MIDDLE EAST & AFRICA BIOMARKERS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 108. EUROPE, MIDDLE EAST & AFRICA BIOMARKERS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 109. EUROPE, MIDDLE EAST & AFRICA BIOMARKERS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
• TABLE 110. EUROPE, MIDDLE EAST & AFRICA BIOMARKERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 111. DENMARK BIOMARKERS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 112. DENMARK BIOMARKERS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 113. DENMARK BIOMARKERS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
• TABLE 114. DENMARK BIOMARKERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 115. EGYPT BIOMARKERS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 116. EGYPT BIOMARKERS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 117. EGYPT BIOMARKERS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
• TABLE 118. EGYPT BIOMARKERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 119. FINLAND BIOMARKERS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 120. FINLAND BIOMARKERS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 121. FINLAND BIOMARKERS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
• TABLE 122. FINLAND BIOMARKERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 123. FRANCE BIOMARKERS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 124. FRANCE BIOMARKERS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 125. FRANCE BIOMARKERS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
• TABLE 126. FRANCE BIOMARKERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 127. GERMANY BIOMARKERS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 128. GERMANY BIOMARKERS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 129. GERMANY BIOMARKERS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
• TABLE 130. GERMANY BIOMARKERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 131. ISRAEL BIOMARKERS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 132. ISRAEL BIOMARKERS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 133. ISRAEL BIOMARKERS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
• TABLE 134. ISRAEL BIOMARKERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 135. ITALY BIOMARKERS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 136. ITALY BIOMARKERS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 137. ITALY BIOMARKERS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
• TABLE 138. ITALY BIOMARKERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 139. NETHERLANDS BIOMARKERS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 140. NETHERLANDS BIOMARKERS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 141. NETHERLANDS BIOMARKERS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
• TABLE 142. NETHERLANDS BIOMARKERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 143. NIGERIA BIOMARKERS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 144. NIGERIA BIOMARKERS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 145. NIGERIA BIOMARKERS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
• TABLE 146. NIGERIA BIOMARKERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 147. NORWAY BIOMARKERS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 148. NORWAY BIOMARKERS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 149. NORWAY BIOMARKERS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
• TABLE 150. NORWAY BIOMARKERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 151. POLAND BIOMARKERS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 152. POLAND BIOMARKERS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 153. POLAND BIOMARKERS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
• TABLE 154. POLAND BIOMARKERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 155. QATAR BIOMARKERS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 156. QATAR BIOMARKERS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 157. QATAR BIOMARKERS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
• TABLE 158. QATAR BIOMARKERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 159. RUSSIA BIOMARKERS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 160. RUSSIA BIOMARKERS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 161. RUSSIA BIOMARKERS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
• TABLE 162. RUSSIA BIOMARKERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 163. SAUDI ARABIA BIOMARKERS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 164. SAUDI ARABIA BIOMARKERS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 165. SAUDI ARABIA BIOMARKERS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
• TABLE 166. SAUDI ARABIA BIOMARKERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 167. SOUTH AFRICA BIOMARKERS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 168. SOUTH AFRICA BIOMARKERS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 169. SOUTH AFRICA BIOMARKERS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
• TABLE 170. SOUTH AFRICA BIOMARKERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 171. SPAIN BIOMARKERS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 172. SPAIN BIOMARKERS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 173. SPAIN BIOMARKERS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
• TABLE 174. SPAIN BIOMARKERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 175. SWEDEN BIOMARKERS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 176. SWEDEN BIOMARKERS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 177. SWEDEN BIOMARKERS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
• TABLE 178. SWEDEN BIOMARKERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 179. SWITZERLAND BIOMARKERS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 180. SWITZERLAND BIOMARKERS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 181. SWITZERLAND BIOMARKERS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
• TABLE 182. SWITZERLAND BIOMARKERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 183. TURKEY BIOMARKERS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 184. TURKEY BIOMARKERS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 185. TURKEY BIOMARKERS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
• TABLE 186. TURKEY BIOMARKERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 187. UNITED ARAB EMIRATES BIOMARKERS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 188. UNITED ARAB EMIRATES BIOMARKERS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 189. UNITED ARAB EMIRATES BIOMARKERS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
• TABLE 190. UNITED ARAB EMIRATES BIOMARKERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 191. UNITED KINGDOM BIOMARKERS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 192. UNITED KINGDOM BIOMARKERS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 193. UNITED KINGDOM BIOMARKERS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
• TABLE 194. UNITED KINGDOM BIOMARKERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 195. BIOMARKERS MARKET, FPNV POSITIONING MATRIX, 2022
• TABLE 196. BIOMARKERS MARKET SHARE, BY KEY PLAYER, 2022
• TABLE 197. BIOMARKERS MARKET LICENSE & PRICING